Potentially huge legal issues are hovering over Kenvue. But Kimberly-Clark, which agreed to buy it for $40 billion, appears ...

The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven ...

The agreement, which combines the maker of Huggies diapers with the owner of the painkiller brand, will create a global ...

Kleenex maker Kimberly-Clark will buy Kenvue at a 46% premium, tanking its own stock by 13%. Synergies promise a decent ...

Mike Hsu aims to stoke the consumer company’s growth by veering into Kenvue’s higher-margin but risky health products.

Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive ...

Huggies maker Kimberly-Clark announced Monday it will buy Tylenol’s parent company Kenvue in a nearly $50 billion deal, ...

Kimberly-Clark Corp. will acquire Tylenol maker Kenvue Inc. in a cash and stock deal valued at almost $49 billion the two ...

Kenvue missed Wall Street estimates for third-quarter sales on Monday, while it also announced its acquisition by ...

One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the common ...

Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive ...

The deal will unite two giants in the over-the-counter health business, bringing together brands like Kleenex and Benadryl.